These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3466770)

  • 1. Consensus development summaries. The impact of routine HTLV-III antibody testing of blood and plasma donors on public health. National Institutes of Health.
    Conn Med; 1986 Nov; 50(11):745-51. PubMed ID: 3466770
    [No Abstract]   [Full Text] [Related]  

  • 2. The impact on public health of routine HTLV-III antibody testing. A National Institutes of Health consensus report synopsis.
    Indiana Med; 1987 Mar; 80(3):250-3. PubMed ID: 3471813
    [No Abstract]   [Full Text] [Related]  

  • 3. The impact of routine HTLV-III antibody testing on public health.
    Natl Inst Health Consens Dev Conf Consens Statement; 1986; 6(5):1-9. PubMed ID: 3537748
    [No Abstract]   [Full Text] [Related]  

  • 4. Consensus conference. The impact of routine HTLV-III antibody testing of blood and plasma donors on public health.
    JAMA; 1986 Oct; 256(13):1778-83. PubMed ID: 3018308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Anti-HTLV III/LAV antibodies of the IgM class in subjects at risk with negative anti-HTLV III/LAV IgG ELISA results (preliminary results)].
    Bedarida G; D'Agostino F; Ronsivalle MG; Berto E; Cambiè G; Berto N; Grisi ME; Arcidiacono I; Sterza G
    Riv Emoter Immunoematol; 1986; 33(1):75-87. PubMed ID: 3532290
    [No Abstract]   [Full Text] [Related]  

  • 6. Update on HIV infection. HIV antibody testing.
    Matuszak DL; Israel E; Horman JT; Joseph JM
    Md Med J; 1987 Jan; 36(1):40-3. PubMed ID: 3645235
    [No Abstract]   [Full Text] [Related]  

  • 7. Anti-HTLV III testing of blood donors and recipients, Hawaii experience.
    Frohlich J
    Hawaii Med J; 1986 Nov; 45(11):391-2. PubMed ID: 3468095
    [No Abstract]   [Full Text] [Related]  

  • 8. Screening donated blood and plasma for HTLV-III antibody. Facing more than one crisis?
    Osterholm MT; Bowman RJ; Chopek MW; McCullough JJ; Korlath JA; Polesky HF
    N Engl J Med; 1985 May; 312(18):1185-9. PubMed ID: 2984568
    [No Abstract]   [Full Text] [Related]  

  • 9. An analysis of serum samples positive for HTLV-III antibodies.
    Petricciani JC; Seto B; Wells M; Quinnan G; McDougal JS; Bodner AJ
    N Engl J Med; 1985 Jul; 313(1):47-8. PubMed ID: 2582255
    [No Abstract]   [Full Text] [Related]  

  • 10. Assessment of screening as a preventive technology: the example of HTLV-III/LAV antibody testing.
    Ory HW; Koplan JP; Allen JR
    Isr J Med Sci; 1986; 22(7-8):524-8. PubMed ID: 3640749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Counseling HIV-antibody positive blood donors.
    Van Devanter NL; Grisaffi JA; Steilen M; Scarola ME; Shipton RM; Tendler C; Pindyck J
    Am J Nurs; 1987 Aug; 87(8):1026-30. PubMed ID: 3474900
    [No Abstract]   [Full Text] [Related]  

  • 12. Prevalence of HTLV-III/LAV antibody in selected populations in Thailand.
    Wangroongsarb Y; Weniger BG; Wasi C; Traisupa A; Kunasol P; Rojanapithayakorn W; Fucharoen S
    Southeast Asian J Trop Med Public Health; 1985 Dec; 16(4):517-20. PubMed ID: 3869739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Provisional Public Health Service inter-agency recommendations for screening donated blood and plasma for antibody to the virus causing acquired immunodeficiency syndrome.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1985 Jan; 34(1):1-5. PubMed ID: 2981394
    [No Abstract]   [Full Text] [Related]  

  • 14. HTLV-III: the etiologic agent of AIDS.
    Sarngadharan MG; DeVico AL; Bruch L; Schüpbach J; Gallo RC
    Princess Takamatsu Symp; 1984; 15():301-8. PubMed ID: 6100648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update: November 1987 testing for AIDS.
    Ezell LD; Texter EC
    J Ark Med Soc; 1987 Nov; 84(6):225-9. PubMed ID: 2961726
    [No Abstract]   [Full Text] [Related]  

  • 16. Prevalence of antibodies to HTLV-III in AIDS risk groups in West Germany.
    Erfle V; Hehlmann R; Mellert W; Krüger G; Seifried E; Heimpel H; Rasokat H; Lechler E; Holzer E; Hellstern P
    Cancer Res; 1985 Sep; 45(9 Suppl):4627s-4629s. PubMed ID: 3860292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening blood: public health and medical uncertainty.
    Levine C; Bayer R
    Hastings Cent Rep; 1985 Aug; 15(4):suppl 8-11. PubMed ID: 2997086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Anti-HTLV-III antibodies. Methods of detection and biological significance].
    Ercilla MG; Barrera JM
    Med Clin (Barc); 1986 Jan; 86(3):123-5. PubMed ID: 3457227
    [No Abstract]   [Full Text] [Related]  

  • 19. [Practical significance of the AIDS problem in blood donation services].
    Wernet P
    Beitr Infusionther Klin Ernahr; 1986; 15():39-50. PubMed ID: 3019300
    [No Abstract]   [Full Text] [Related]  

  • 20. HIV testing for NIH laboratory workers gets under way.
    Palca J
    Nature; 1988 Mar; 332(6163):386. PubMed ID: 3162553
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.